Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand

Apr.23
Philip Morris International Says Part of Owensboro ZYN Output Is Exceeding Market Demand
Philip Morris International said its Swedish Match facility in Owensboro will adjust part of its production schedule this summer in response to changing market conditions. According to a notice the company gave union leadership and employees on April 22, parts of ZYN production will shift from a 24/7 schedule back to a 24/5 schedule. The ZYN Flagship department will return to a five-day, three-shift operation.

Key Takeaways

  • PMI U.S. told union leadership and employees on April 22 that part of ZYN production in Owensboro will shift from 24/7 to 24/5.
  • The change mainly affects the ZYN Flagship department, which will return to a five-day, three-shift schedule.
  • The company said recent market conditions mean the ZYN Flagship department is currently exceeding market demand.
  • The adjustment is targeted for implementation by July 6.
  • PMI said ZYN Ultra production and maintenance operations are expected to remain on a 24/7 schedule.

2Firsts, April,23 2026 

 

According to Owensboro Times, the Swedish Match facility in Owensboro will adjust part of its production schedule this summer. 

 

Philip Morris International U.S. officials said the company informed union leadership and employees on April 22 that portions of ZYN production will move from a 24/7 schedule back to a 24/5 schedule, in line with the default terms in the collective bargaining agreement.


The ZYN Flagship department will return to a five-day, three-shift operation


The report said the change primarily affects the ZYN Flagship department, which will return to a five-day, three-shift schedule. Company leaders said the adjustment is intended to rebalance production after a period of heightened demand and expansion.


The company said part of production is now exceeding market demand


In a letter to union officials viewed by Owensboro Times, PMI U.S. Vice President of U.S. Manufacturing Shane Dukes said PMI U.S. and the union share the same goal of producing the highest quality products to meet customer demand. He wrote that market conditions have recently changed and, as a result, the ZYN Flagship department is exceeding market demand.


Dukes said the company intends to implement the change by July 6.


The company said the move is not a closure or relocation


The report said the Owensboro facility had moved to continuous 24/7 production during a recent expansion period. PMI invested more than $230 million into the site in 2024, increasing capacity and creating about 450 jobs to meet surging demand for ZYN nicotine pouches.


Company officials said the current adjustment reflects a “normalization” following that ramp-up phase. In an emailed statement to Owensboro Times, a company spokesperson said the change is a production schedule adjustment driven by market conditions, not a facility closure or relocation, and that Owensboro remains central to PMI U.S.’s ZYN operations.


Not all operations will be affected


According to the letter, the change will not affect all operations. ZYN Ultra production and maintenance operations are expected to remain on a 24/7 schedule.


Under the revised plan, employees in affected departments will return to schedules set out in the collective bargaining agreement. The company said it will work with union leadership to address job assignments, seniority considerations and shift preferences during the transition.


The company said it is giving about 10 weeks’ notice


The report said Article V of the agreement requires at least one week’s notice for operational changes. In the letter, the company said it is providing about 10 weeks’ notice to allow employees time to prepare.


PMI also said in the letter that it may return the Flagship department to a 24/7 schedule in the future if market demand warrants.
Image Source:

Image Source: Owensboro Times

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Korean component maker ITM Semiconductor says Indonesia unit starts e-cigarette device output as related Q1 revenue rises 55.4%
Korean component maker ITM Semiconductor says Indonesia unit starts e-cigarette device output as related Q1 revenue rises 55.4%
South Korea’s KOSDAQ-listed electronics-component maker ITM Semiconductor said its Indonesia subsidiary has begun full-scale mass production of e-cigarette devices, with first-quarter revenue from the business rising 55.4% year on year to 42.1 billion won, Maeil Business Newspaper reported.
Jul.08
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
The Alabama Supreme Court affirmed a lower court’s refusal to issue a preliminary injunction blocking the state’s 2025 electronic nicotine delivery systems law, allowing rules requiring covered products to be U.S.-made or FDA-authorized to remain in effect.
Jul.10